Close Menu

This article has been updated from a previous version.

NEW YORK, July 16 - Signature BioScience has acquired Cambridge Discovery Chemistry (CDC) from Millennium Pharmaceuticals, filling the company's need for chemists who can design small molecule drugs, Signature CEO Mark McDade told GenomeWeb Monday. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.